Research programme: varicella zoster vaccine - Novavax

Drug Profile

Research programme: varicella zoster vaccine - Novavax

Alternative Names: Shingles vaccine - Novavax; Varicella zoster virus (VZV) vaccine - Novavax; VZV VLP vaccine - Novavax

Latest Information Update: 09 Oct 2013

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Novavax
  • Class Virus-like particle vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Varicella zoster virus infections

Most Recent Events

  • 09 Oct 2013 No development reported - Preclinical for Varicella zoster virus infections (prevention) in USA (Parenteral)
  • 19 Sep 2007 Early research in Varicella zoster virus infections in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top